Articles tagged with Endometriosis
A mouse model of endometriosis has been developed that produces lesions similar to those found in humans. The study suggests that macrophages present in shed endometrium contribute to the development of endometriotic lesions, providing new insights into the disease.
Researchers uncover complement pathway as primary immune mechanism driving endometriosis and ovarian cancer development. The discovery may lead to targeted preventive measures, such as immune therapy, for women with endometriosis at increased cancer risk.
A new theory proposes that epigenetic modification plays a key role in the development of endometriosis, a chronic disease affecting 1 in 10 women. The research suggests that alterations in the epigenetic landscape, rather than genetic mutations, contribute to the disease's progression.
Researchers have identified a distinctive profile of cytokine activity associated with certain symptoms of endometriosis, including ovarian and rectovaginal lesions. This signature is negatively correlated with patient fertility and has previously been implicated in the disease.
A Fred Hutchinson Cancer Center-led study has found a link between two organochlorine pesticides and an increased risk of endometriosis. Women with higher exposures to these pesticides had a 30- to 70-percent increase in endometriosis risk, according to the study.
A recent study found that morbidly obese women have a significantly lower risk of developing endometriosis compared to those with low normal BMI. The association was strongest in infertile women, who had a 77% lower rate of endometriosis
A research team led by Nalini Santanam is investigating the epigenetics of pain in endometriosis, with preliminary findings suggesting that epigenetic markers may play a role in the disease's development. The team hopes to find new biomarkers for diagnostics and personalized treatment approaches.
A novel study suggests that surgical removal of an ovary and visible endometriosis significantly lower ovarian cancer risk in women with endometriosis. Hormonal treatments, however, did not show a protective effect against ovarian cancer.
Researchers have discovered a potent physiological anti-angiogenic factor, PEDF, that reverses symptoms of endometriosis and ovarian hyperstimulation syndrome without compromising fertility. The injectable protein has shown promising results in pre-clinical studies.
A possible link between benzophenone sunscreens and endometriosis has been identified by researchers. High levels of 2,4OH-BP were associated with an increased risk of endometriosis diagnosis in a study of 625 women.
Women with a history of endometriosis are at a significantly higher risk of developing three specific types of ovarian cancer. The study found that endometriosis is linked to a more than threefold chance of developing clear-cell ovarian cancers and over double the risk of developing endometrioid tumours.
Researchers at Yale University have discovered a new gene mutation that provides hope for new screening methods to identify women at risk of developing endometriosis. The study found that 31% of women with endometriosis carried the mutation, compared to 5.8% of the general population.
A nationwide Danish cohort study suggests women with endometriosis are 50% more likely to develop inflammatory bowel disease, a condition that affects the bowel and causes abdominal pain. The risk persists for over 20 years after diagnosis and is linked to common causes or treatment effects.
Research identifies two genetic variants associated with an increased risk of developing endometriosis, a condition characterized by pelvic pain and infertility. The variants were found on chromosomes 7 and 1, respectively, and are linked to hormone metabolism and the development of the female reproductive tract.
The study found substantial differences between women with endometriosis and controls, with lost work productivity averaging ten hours per week. Quality of life was also significantly impaired, except for physical functioning and mental health.
A study of 70,709 American nurses found that consuming long-chain Omega-3 fatty acids may reduce the risk of endometriosis by 22%, while eating trans fats increases the risk by 48%. Dietary changes, such as reducing trans fats and increasing Omega-3 oils, may be a useful strategy for preventing or alleviating endometriosis symptoms.
A new study found that strong period pain experienced in adolescence doubles a woman's risk of developing endometriosis. Early menstrual cycle characteristics, including age at menarche, also play a significant role in the development of the disease.
Endometriosis affects an estimated 1 in 10 women during their reproductive years, causing severe symptoms, infertility, and chronic pain. The EndoCost study aims to assess the societal costs of endometriosis and identify areas for improvement.
Researchers have discovered a quick and accurate way to diagnose endometriosis by testing for nerve fibres in endometrial biopsies. The test shows high specificity and sensitivity, potentially reducing lengthy delays in diagnosis and improving treatment planning.
A new study published in Radiology found that MRI can accurately diagnose deep endometriosis and locate lesions prior to surgery. The technique was effective in detecting the disease's extent and involvement of surrounding organs, such as the colon and bladder.
A study published in Human Reproduction found that women with endometriosis are at a higher risk of premature birth, C-sections, and other pregnancy complications. The researchers also found that women with endometriosis were more likely to have difficulty conceiving and required assisted reproduction technology.
Key epigenetic abnormalities in endometriosis have been identified, including the presence of aromatase, which produces excessive estrogen in affected tissue. Aromatase inhibitors are now being tested for treatment options.
Researchers at the University of Liverpool discovered that an enzyme called telomerase is released by cells in the inner lining of the womb during the menstrual cycle, contributing to endometriosis. The abnormal length of telomeres and expression of telomerase in endometrial cells may lead to severe pain and infertility.
A new study found that uncontrollable stress worsens symptoms of endometriosis in rats by activating inflammatory mechanisms and damaging organs. The study, conducted on seven female rats, showed that stressed animals developed more severe lesions and organ damage than unstressed controls.
A case report describes a woman with small bowel endometriosis who presented symptoms similar to Crohn's disease. Histopathological examination confirmed the diagnosis of Crohn's disease, highlighting the need for accurate differential diagnosis in clinical practice.
Experimental studies suggest that targeting angiogenesis with dopamine agonists and dendritic cell inhibitors may inhibit endometrial lesions and decrease cancer risk. Mouse models show reduced blood vessel formation and increased old blood vessels in treatment groups.
Women with endometriosis face a higher risk of certain cancers, including ovarian, kidney, and thyroid cancer. However, the risk is not affected by whether or not they have given birth. Conversely, women with endometriosis are less likely to develop cervical cancer.
Women with endometriosis often experience chronic pain, reduced quality of life, and suicidal feelings due to delayed diagnosis. The study highlights the need for better awareness and pain management services for this condition.
A new Italian study found that women with endometriosis have a significantly higher prevalence of migraine, but no link to attack frequency or pain intensity. The study also suggests that investigating headaches in women with endometriosis is crucial for proper diagnosis and treatment.
Italian researchers found a 40% relative reduction in endometriosis risk among women consuming higher amounts of green vegetables and fresh fruit. Conversely, high consumption of beef, other red meat, and ham was associated with an increased risk, potentially leading to a 3-4% decrease in prevalence if confirmed by future studies.
Researchers tested angiostatic therapy on mice with endometriosis lesions, finding it inhibited new blood vessel growth and reduced existing lesion size. The most effective compound was endostatin, which also showed no side effects in animal trials.
A new study finds aromatase inhibitors can significantly reduce endometriosis severity and pain, offering a more effective treatment with fewer side effects. The treatment involves taking letrozole along with progestin for six months, resulting in improved symptoms and reduced estrogen production.
Researchers found a slightly increased risk of ovarian cancer in women with endometriosis, with a half-life increase and higher risks for younger women. In contrast, the risk of cervical cancer was reduced by roughly a third. Further investigation is needed to understand the connection between endometriosis and cancer.
A Stanford-led team discovered 12 genes relevant to endometriosis-related infertility, offering potential targets for new treatments. These findings could lead to improved diagnosis and treatment of the disease, reducing reliance on surgery and medication.
A preliminary study found that the peritoneal fluid of women with early-stage endometriosis reduces ciliary beat frequency by around a quarter compared to fertile controls. This reduction may be linked to impaired ciliary action and tubal transport, which could negatively impact fertility.
A recent survey of 968 women aged 15-59 found that nearly 60% were told their pain is normal by their Ob/Gyn or a friend/family member. Chronic pelvic pain affects many lives, but often takes years to receive an accurate diagnosis.
Women with endometriosis have a higher prevalence of autoimmune inflammatory diseases, hypothyroidism, fibromyalgia, chronic fatigue syndrome, allergies, and asthma. A 10-year delay between symptom onset and diagnosis is common, prompting doctors to consider endometriosis in girls and women with pelvic pain.
A commonly prescribed medication for treating endometriosis appears to elevate the risk of ovarian cancer, according to a new study. Women taking danazol were nearly three times more likely to develop ovarian cancer than those taking leuprolide, an anti-androgenic medication.
The University of Illinois Chicago has received a five-year, $7 million NIH grant to study the mechanisms of fertility and infertility. Researchers will investigate hormone regulation, immune response, and other factors contributing to endometriosis and infertility.
A unique Icelandic study reveals a significant genetic component to endometriosis, with affected women being more interrelated than control groups. The research suggests that women at risk may benefit from earlier pregnancy or diagnostic tests.
A new study suggests that proteins alphav-beta3 and leukemia inhibitory factor (LIF) may serve as biomarkers for identifying women with endometriosis-related infertility. The research found a marked reduction in embryo implantation in mice injected with peritoneal fluid from infertile women with endometriosis.
Researchers find that while smoking may lower risk of pre-eclampsia and uterine cancer, it can lead to reproductive problems such as miscarriage and infertility. Stopping smoking during pregnancy is advised, with nicotine alternatives like gum recommended to minimize harm.
A prospective study conducted by researchers at the University at Buffalo found that surgery for endometriosis dramatically improves pain and discomfort in most women. The study also showed that women who had previously given birth were twice as likely to get pregnant again following surgery, while advancing age reduced fertility.